During SARS-CoV-2 infection, two phases can be observed: 1) an early phase with weak IFNα/IFNβ production and limited antiviral responses and 2) an excessive inflammatory immune response which can give rise to cytokine storms or acute respiratory distress syndrome. This evidence concerns the gene IFNA1 and acute respiratory distress syndrome.